Logged in as: Guest
WCN'24 Home
View detailed Congress Program
View Program at a glance
LOGIN
THE USE OF MONOCLONAL ANTIBODIES (TIXAGEVIMAB AND CIGLAVIMAB) FOR PRE-EXPOSURE PROPHYLAXIS OF SEVERE COVID-19 INFECTION IN PATIENTS ON HEMODIALYSIS.
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/86aad696fae30de582b525ba1222914c.pdf
Abstract Title
THE USE OF MONOCLONAL ANTIBODIES (TIXAGEVIMAB AND CIGLAVIMAB) FOR PRE-EXPOSURE PROPHYLAXIS OF SEVERE COVID-19 INFECTION IN PATIENTS ON HEMODIALYSIS.
First Name *
Elena
Last Name *
Zakharova
Co-author 1
Evgeny Shutov shutov_e_v@mail.ru Botkin Hospital, Moscow, Russia nephrology Moscow
Co-author 2
Stepan Bolshakov bolshakoff123@yandex.ru Botkin Hospital, Moscow, Russia nephrology Moscow
Co-author 3
Alina Jarullaeva jar@mail.ru N.F.Gamaleya, National Research Center virology Moscow
Co-author 4
Inna Dolzhikova dolzhikova@mail.ru N.F.Gamaleya, National Research Center virology Moscow
Co-author 5
Elena Zakharova helena.zakharova@gmail.com Botkin Hospital, Moscow, Russia nephrology Moscow
Co-author 6
Sergey Sorokoletov Сергей Сороколетов
Botkin Hospital, Moscow, Russia therapy Moscow
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
